Physiomics PLCPYC:LSE

0.0311
0.00 / 4.31%
5.94m
72.96 %
1.55
Latest price in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Feb 10 2016 10:26 GMT.
PYC:LSE is traded on the London Stock Exchange Alternative Investment Market (Aim)

Summary

As of last trade Physiomics PLC (PYC:LSE) traded at 0.0311, 3.67% above its 52-week low of 0.03, set on Dec 24, 2015.

52-week range
Today
0.03
Dec 24 2015
0.167
Mar 03 2015
Open0.0325
Day high--
Day low--
Bid0.03
Offer0.035
Previous close0.0325
Average volume5.82m
Shares outstanding3.48bn
Free float3.39bn
P/E (TTM)--
Market cap1.13m GBP
EPS (TTM)-0.0002 GBP
Data delayed at least 15 minutes, as of Feb 10 2016 10:26 GMT.

RNS Company announcements

Issue of Options
New Speciality Pharma Customer for New Indication
Placing
Result of General Meeting
Result of AGM

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Physiomics PLC-17.07 %-30.89 %-43.45 %-72.96 %-91.59 %
FTSE 100 IDX-2.22 %-3.47 %-13.15 %-16.43 %-5.19 %
Data delayed at least 15 minutes, as of Feb 10 2016 10:26 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.